Literature DB >> 155335

Stimulation of allogeneic lymphocytes by skin epidermal cells in the rat.

S Tanaka, A Sakai.   

Abstract

The ability of skin epidermal cells to induce allogeneic lymphocytes into proliferation was examined in mixed skin cell-lymphocyte culture reaction (MSLR). The stimulating capacity of skin cells was reduced significantly by trypsin digestion, although the damage was repaired by incubation at 37 C for 3 hr. The optimal concentration of mitomycin C for treatment of stimulating cells in the MSLR differed from that in mixed lymphocyte culture reaction (MLR). Irradiation rendered them three to four times more stimulatory than did mitomycin C. Removal of adherent cells from responding cells by passage through a nylon-wool column gave a substantial elevation of the MSLR. The lymphocytes cocultured with skin cells in the primary MSLR incorporated 3H-thymidine, with the peak at the 6th day of culture. If the lymphocytes primed in the MSLR were restimulated with skin cells from the same stimulating strain, the primed lymphocytes responded promptly and in great magnitude.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 155335     DOI: 10.1097/00007890-197903000-00011

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations.

Authors:  J Czernielewski; M Faure; D Schmitt; J Thivolet
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

2.  Class II MHC antigen expression by human keratinocytes results from lympho-epidermal interactions and gamma-interferon production.

Authors:  J M Czernielewski; M Bagot
Journal:  Clin Exp Immunol       Date:  1986-11       Impact factor: 4.330

3.  Accessory and stimulating properties of dendritic cells and macrophages isolated from various rat tissues.

Authors:  W E Klinkert; J H LaBadie; W E Bowers
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.